The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGb Group Regulatory News (GBG)

Share Price Information for Gb Group (GBG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 288.00
Bid: 285.60
Ask: 286.60
Change: -2.20 (-0.76%)
Spread: 1.00 (0.35%)
Open: 289.00
High: 299.40
Low: 285.20
Prev. Close: 290.20
GBG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading update

21 Feb 2023 07:00

RNS Number : 5045Q
GB Group PLC
20 February 2023
 

 

21 February 2023

GB GROUP PLC

("GBG", "Group" or the "Company")

Trading update

GBG, (AIM: GBG) the experts in digital location, identity verification and fraud software, today provides the following trading update.

At our interim results in late November 2022, we reported on the trends that had been impacting our end markets for identity services, most notably the challenging conditions for cryptocurrency and our internet economy customers. These challenging conditions have continued into the second half of the year and given the relative concentration of these customers in our North America business this is the region where we are seeing the most pronounced impact. We have also seen some incremental lengthening of sales cycles, also in North America, as a result of the macro-economic uncertainty and this has delayed some expected customer contracts.

As a result, the Board now expects GBG to report revenue for the year ending 31 March 2023 of approximately £279 million (FY22: pro forma revenue of £273.8 million). Excluding £4.2 million revenue from US stimulus customers in the comparative period, the full effect (c. £15 million) of the year-on-year decline in revenues from cryptocurrency customers and the FY23 impact of the deferred revenue haircut (£1.2 million), this would equate to organic pro forma constant currency growth of approximately 4% for the financial year, almost evenly split between the first half and second half of the year.

Adjusted operating profit is anticipated to be approximately £60 million, representing a margin of 21.5%. Gains on foreign exchange included within adjusted operating profit are expected to be approximately £3 million.

As we approach our new financial year and as we move through these headwinds, the Board's current expectation is that organic constant currency revenue growth is likely to improve gradually through the period from current levels towards high single-digits in the latter part of the year. Strong control of cost is anticipated to sustain FY24 adjusted operating profit margins at around current levels, without compromising ongoing investment in the business which will support achieving our medium-term guidance for growth and profitability.

Chris Clark, CEO, commented:

"The difficult macroeconomic environment has been well publicised and it is disappointing to have seen the impact on certain parts of our business. However, GBG continues to achieve growth and maintain strong operating margins and cash generation. GBG's services remain crucial for customers to operate safely and efficiently in an ever more digital world and the Board remains confident in the long-term opportunities."

GBG will publish a full year pre-close trading statement in April 2023.

This announcement contains Inside Information as defined in Article 7 of the Market Abuse Regulation. The person responsible for arranging the release of this announcement on behalf of GB Group plc is Annabelle Burton, Company Secretary.

For further information, please contact:

GBG

Chris Clark, CEO & David Ward, CFO

Richard Foster, Investor Relations

 

 

+44 (0) 1244 657333

+44 (0) 7816 124164

Numis (Nominated Adviser and Corporate Broker)

Simon Willis & Joshua Hughes

 

+44 (0) 207 260 1000

 

Barclays (Corporate Broker)

Stuart Jempson & Rob Mayhew

+44 (0) 207 623 2323

 

Teneo (Financial PR)

James Macey White & Matt Low

+44 (0) 20 7353 4200

GBG@tulchangroup.com

 

Website

www.gbgplc.com/investors

About GBG

We are the experts in digital location, identity and managing fraud risk and compliance. Helping organisations across the globe eliminate customer friction and fraud from their digital experiences. GBG develop and deliver digital identity, address verification, fraud prevention and compliance software to businesses globally.

Through the combination of the latest technology, the most accurate data and our unrivalled expertise, GBG helps organisations ranging from start-ups to the largest consumer and technology brands in the world deliver seamless experiences, so their customers can transact online with greater confidence.

To find out more about how we help our customers establish trust with their customers visit www.gbgplc.com and follow us on LinkedIn and Twitter @gbgplc.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTDDGDDSBDDGXG
Date   Source Headline
26th Apr 20242:33 pmRNSHolding(s) in Company
23rd Apr 20247:00 amRNSFY24 trading update
28th Mar 202412:47 pmRNSTotal Voting Rights
29th Feb 20243:44 pmRNSTotal Voting Rights
31st Jan 20244:59 pmRNSDirector/PDMR Shareholding
31st Jan 20241:00 pmRNSTotal Voting Rights
30th Jan 20247:00 amRNSDirectorate change and in-line trading update
26th Jan 20248:30 amRNSHolding(s) in Company
19th Jan 202410:01 amRNSBlock listing Interim Review
29th Dec 202311:54 amRNSTotal Voting Rights
19th Dec 20238:50 amRNSHolding(s) in Company
4th Dec 20231:49 pmRNSDirector/PDMR Shareholding
30th Nov 20232:12 pmRNSTotal Voting Rights
28th Nov 20237:00 amRNSHalf-year Report
8th Nov 20237:00 amRNSDirectorate Change
31st Oct 20233:15 pmRNSTotal Voting Rights
23rd Oct 20232:12 pmRNSHolding(s) in Company
19th Oct 20237:00 amRNSHalf-year trading update
29th Sep 20237:00 amRNSTotal Voting Rights
31st Aug 20232:03 pmRNSTotal Voting Rights - Correction
31st Aug 20237:00 amRNSTotal Voting Rights
10th Aug 20234:47 pmRNSPDMR shareholding, Issue of Ordinary Shares & TVR
31st Jul 20237:00 amRNSTotal Voting Rights
20th Jul 202312:26 pmRNSResult of AGM
20th Jul 20237:00 amRNSAGM Statement
19th Jul 20237:00 amRNSBlock listing Interim Review
14th Jul 20232:13 pmRNSDirector/PDMR Shareholding
30th Jun 20237:00 amRNSTotal Voting Rights
26th Jun 20235:24 pmRNSPosting of Annual Report and Notice of AGM
15th Jun 20237:00 amRNSFinal Results
31st May 20237:00 amRNSTotal Voting Rights
2nd May 20232:01 pmRNSTotal Voting Rights
24th Apr 20237:00 amRNSDirector Dealing
20th Apr 20237:00 amRNSPre-close trading update
6th Apr 20233:01 pmRNSHolding(s) in Company
31st Mar 20237:00 amRNSTotal Voting Rights
29th Mar 202312:59 pmRNSHolding(s) in Company
24th Mar 20238:58 amRNSHolding(s) in Company
23rd Mar 20237:00 amRNSDirector Retirement
28th Feb 20237:00 amRNSTotal Voting Rights
22nd Feb 20237:00 amRNSDirector Dealing
21st Feb 20237:00 amRNSTrading update
7th Feb 20237:00 amRNSBlock listing Interim Review
31st Jan 20237:00 amRNSTotal Voting Rights
24th Jan 20233:30 pmRNSHolding(s) in Company
19th Jan 20237:00 amRNSCapital Markets Event
29th Nov 20227:00 amRNSHalf-year Report
11th Nov 20228:42 amRNSHolding(s) in Company
7th Nov 20227:00 amRNSHolding(s) in Company
1st Nov 202212:03 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.